# BEAT BioTherapeutics Corp — Form D

BEAT BioTherapeutics Corp of BELLEVUE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2013-04-16. The offering totals $2.5M, of which $2.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2013-04-16
- Form: D
- Accession: 0001574133-13-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.5M
- Amount sold: $2.4M
- Remaining: $100K
- Investors: 21
- Date of first sale: 2013-04-08
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-195092

## Issuer

- Name: BEAT BioTherapeutics Corp
- CIK: 0001574133
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 1380 - 112TH AVE. NE, SUITE 200, BELLEVUE, WA, 98004
- Phone: (425) 269-3478

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Michael Kranda | Director | Bellevue, WA |
| Jim Leggett | Director | Bellevue, WA |
| Greg Mahairas, Ph.D. | Director | Bellevue, WA |
| Craig Tall | Director | Mercer Island, WA |
| Michael Kranda | Executive Officer | Bellevue, WA |
| Greg Mahairas, Ph.D. | Executive Officer | Bellevue, WA |

## More

- [CIK 1574133 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1574133&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001574133-13-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.